Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 4, 2013, Pages 543-549

  Botezatu, Anca ^a   Socolov, Demetra ^b   Iancu, Iulia V ^a   Huica, Irina ^a   Plesa, Adriana ^a   Ungureanu, Carmen ^b   Anton, Gabriela ^a  

^a STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Cervical cancer; DNA methylation; HrHPV; MTHFR polymorphism

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; ARTICLE; DNA METHYLATION; DNA SEQUENCE; ENZYMOLOGY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETICS; HUMAN; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84877011655     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12032     Document Type: Article

References (40)

1. zur Hausen H. Human papilloma viruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol. 1977; 78: 1-30.
2. Chan K, Monk BJ, Brewer C, et al. HPV infection and number of lifetime sexual partners are strong predictors for natural regression of CIN 2 and 3. Br J Cancer. 2003; 89: 1062-6.
3. Kjellberg L, Wang Z, Wiklund F, et al. Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study. J Gen Virol. 1999; 80: 391-8.
4. Slattery ML, Robison LM, Schuman KL, et al. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA. 1989; 261: 1593-8.
5. Brinton LA, Reeves WC, Brenes MM, et al. Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol. 1990; 19: 4-11.
6. 12, and homocysteine. Cancer Epidemiol Biomarkers Prev. 2000; 9: 761-4.
7. Fowler BM, Giuliano AR, Piyathilake C, et al. Hypomethylation in cervical tissue: is there a correlation with folate status? Cancer Epidemiol Biomarkers Prev. 1998; 7: 901-6.
8. Bailey LB, Gregory JF 3rd. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr. 1999; 29: 919-22.
9. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5, 10 - methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA. 2002; 99: 5606-11.
10. Li XL, Xu JH. MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies, prostate cancer and prostatic diseases. Neuromolecular Med. 2012; 14: 84-90.
11. Chiusolo P, Reddiconto G, Farina G, et al. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients. Leuk Res. 2007; 31: 1669-74.
12. Martin DN, Boersma BJ, Howe TM, et al. Association of MTHFR gene polymorphisms with breast cancer survival. BMC Cancer. 2006; 6: 257-67.
13. Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, et al. A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther. 2010; 12: R71.
14. Frosst P, Blom HG, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10: 11-3.
15. Mu LN, Cao W, Zhang ZF, et al. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Causes Control. 2007; 18: 665-75.
16. Lewis SJ, Ebrahim S, Smith GD. Meta-analysis of MTHFR 677C→ T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ. 2005; 331: 1053.
17. Gershoni-Baruch R, Dagan E, Israeli D, et al. Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur J Cancer. 2000; 36: 2313-6.
18. Wiemels JL, Smith RN, Taylor GM, et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA. 2001; 98: 4004-9.
19. Schnakenberg E, Mehles A, Cario G, et al. Polymorphisms of methylenetetra-hydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Genet. 2005; 6: 23-7.
20. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer. 2004; 4: 143-53.
21. Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science. 1999; 286: 481-6.
22. Costa VL, Henrique R, Ribeiro FR, et al. Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors. BMC Cancer. 2007; 7: 133.
23. Khazamipour N, Noruzinia M, Fatehmanesh P, et al. MTHFR promoter hypermethylation in testicular biopsies of patients with non-obstructive azoospermia: the role of epigenetics in male infertility. Hum Reprod. 2009; 24: 2361-4.
24. Sun Z, Asmann YW, Kalari KR, et al. Integrated analysis of gene expression, CpG Island methylation, and gene copy number in breast cancercells by deep sequencing. PLoS ONE. 2011; 6: e17490.
25. Liu R, Yin L, Pu Y. Association between gene expression of metabolizing enzymes and esophageal squamous cell carcinomas in China. Genet Test Mol Biomarkers. 2012; 16: 1211-7.
26. Fackler MJ, McVeigh M, Mehrotra J, et al. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res. 2004; 64: 4442-52.
27. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007; 370: 890-907.
28. Chen J, Giovannucci E, Kelsey K, et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 1996; 56: 4862-4.
29. Kimura F, Franke KH, Steinhoff C, et al. Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma. Prostate. 2000; 45: 225-31.
30. Shen H, Xu Y, Zheng Y, et al. Polymorphisms of 5, 10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer. 2001; 95: 332-6.
31. Xu XJ, Zou LW, Wang DB. Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis. Mol Biol Rep. 2013; 40: 255-62.
32. Luo YL, Ye P, Zhang QH, et al. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer and cervical intraepithelial neoplasia: a meta-analysis. PLoS ONE. 2012; 7: e46272.
33. Mei Q, Zhou D, Gao J, et al. The association between MTHFR 677C>Tpolymorphism and cervical cancer: evidence from a meta-analysis. BMC Cancer. 2012; 12: 467.
34. Osian G, Procopciuc L, Vlad L. MTHFR polymorphisms as prognostic factors in sporadic colorectal cancer. Gastrointestin Liver Dis. 2007; 16: 251-6.
35. Goodman MT, McDuffie K, Hernandez B, et al. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev. 2001; 10: 1275-80.
36. Lambropoulos AF, Agorastos T, Foka ZJ, et al. Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia. Cancer Lett. 2003; 191: 187-91.
37. Agodi A, Barchitta M, Cipresso R, et al. Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in Sicily. Int J Gynecol Cancer. 2010; 20: 141-6.
38. Kang S, Kim JW, Kang GH, et al. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol. 2005; 96: 173-80.
39. Lai HC, Lin YW, Huang TH, et al. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer. 2008; 123: 161-7.
40. Calvisi DF, Simile MM, Ladu S, et al. Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis. Int J Cancer. 2007; 121: 2410-20.